U.S. Court of Appeals for the 9th Circuit
Jun. 5, 2013
Amgen workers can pursue class action over failed drug, 9th Circuit rules
A failed cancer drug that sent biotech giant Amgen Inc.'s stock plummeting also wrecked employee pension plans, giving workers the right to pursue a class action against the company, a 9th U.S. Circuit Court of Appeals panel held Tuesday.
Daily Journal Staff Writer
A failed cancer drug that sent biotech giant Amgen Inc.'s stock plummeting also wrecked employee pension plans, giving current and former workers the right to pursue a class action against the company over their losses, a 9th U.S. Circuit Court of Appeals panel held Tuesday.
The decision reversed U.S. District Judge Philip S. Gutierrez of Los Angeles, who had held that Thousand Oaks-based Amgen did...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In